Capstone Therapeutics

(OTC:CAPSD)

Symbol has changed to a new ticker symbol

(CAPS)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Capstone Therapeutics Corp is a biotechnology company, which develops a pipeline of novel therapeutic peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs for the treatment of Homozygous Familial Hypercholesterolemia, other hyperlipidemic indications, and acute coronary syndrome/atherosclerosis regression.

Contact Information

Website: www.capstonethx.com
Email: investorinquiries@capstonethx.com
Main Phone: +1 708 371-0660
Address: 5141 West 122nd Street
Address 2: Suite 104
State: IL
City / Town: Alsip
Country: US
Postal Code: 60803

Issuer Information

Exchange: OTCQB
CEO: John M. Holliman
Employees: 2
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A